Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × fludarabine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 85 Precursor Cell Lymphoblastic Leukemia-Lymphoma 54 Myelodysplastic Syndromes 47 Lymphoma, Non-Hodgkin 38 Lymphoma 34 Multiple Myeloma 32 Leukemia, Lymphocytic, Chronic, B-Cell 32 Lymphoma, B-Cell 29 Recurrence 27 Lymphoma, Large B-Cell, Diffuse 27 Hematologic Neoplasms 25 Lymphoma, Follicular 24 Lymphoma, Mantle-Cell 22 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Lymphoma, B-Cell, Marginal Zone 19 Leukemia 19 Myeloproliferative Disorders 18 Melanoma 18 Leukemia, Biphenotypic, Acute 18 Hodgkin Disease 18 Pancreatic Neoplasms 15 Burkitt Lymphoma 15 Ovarian Neoplasms 14 Neoplasms 14 Leukemia, Myelomonocytic, Chronic 12 Anemia, Refractory, with Excess of Blasts 11 Colorectal Neoplasms 9 Stomach Neoplasms 7 Primary Myelofibrosis 7 Osteosarcoma 7

Interventions

Carboplatin 8 pembrolizumab 6 Radiotherapy 5 Pemetrexed 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Radiation 4 Paclitaxel 3 Nivolumab 3 Cisplatin 3 Biopsy 3 fludarabine phosphate 2 durvalumab 2 aldesleukin 2 Taxes 2 Radiotherapy, Conformal 2 Platinum 2 Ipilimumab 2 Interleukin-2 2 Immunoglobulin G 2 Disulfides 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 veliparib 1 trametinib 1 sotorasib 1 rucaparib 1 ribociclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05566223 2026-02-23

CheckCell-2

Intima Bioscience, Inc.

Phase 1/2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡